Haemtech to present on Thrombin Generation Assay applications

Dr. Ryan Dorfman, VP of Operations, will present on Thrombin Generation Assay (TGA) applications at the 2nd Hemophilia Drug Development Summit in Boston, MA on August 21st. During the presentation, Dr. Dorfman will discuss the basics of the thrombin generation assay, and how it can be used to assess bleeding and thrombotic risk in hemophilia patients on therapeutic treatments.

For more information on the Summit please visit https://hemophilia-drug-development.com/